Hepatic enzyme profile in horses

dc.centroUniversidad Cardenal Herrera-CEU
dc.contributor.authorSatué Ambrojo, Katiuska
dc.contributor.authorChicharro Alcántara, Deborah
dc.contributor.authorGardon Poggi, Juan Carlos
dc.contributor.authorMiguel Pastor, Laura
dc.contributor.otherProducción Científica UCH 2022
dc.contributor.otherUCH. Departamento de Medicina y Cirugía Animal
dc.date2022
dc.date.accessioned2023-03-14T05:00:17Z
dc.date.available2023-03-14T05:00:17Z
dc.date.issued2022-03-29
dc.descriptionEste artículo se encuentra disponible en la página web de la revista en la siguiente URL: https://www.mdpi.com/2076-2615/12/7/861
dc.descriptionEste artículo de investigación pertenece al número especial "Hepatic Disease of Equids".
dc.description.abstractFor diagnostic purposes, liver enzymes are usually classified into hepatocellular and cholestatic. These two groups of equine liver-specific enzymes include sorbitol dehydrogenase (SDH), glutamate dehydrogenase (GLDH), -glutamyl transferase (GGT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and alkaline phosphatase (ALP). SDH and GLDH mostly reflect hepatocellular injury and cholestasis, while GGT expresses high values in biliary necrosis or hyperplasia. Likewise, AST, LDH, and ALP also reflect hepatocellular and biliary disease, but these enzymes are not liver specific. From the clinical point of view of the course of liver or biliary disease, AST and ALP are indicative of chronic disease, whereas SDH, GGT, and GLDH indicate an acute course. The patterns of enzymatic changes at the blood level are associated with different types of liver pathologies (infectious, inflammatory, metabolic, toxic, etc.). Increases in hepatocellular versus biliary enzyme activities are indicative of a particular process. There are different ways to diagnose alterations at the hepatic level. These include the evaluation of abnormalities in the predominant pattern of hepatocellular versus cholestatic enzyme abnormalities, the mild, moderate, or marked (5–10-fold or >10-fold) increase in enzyme abnormality concerning the upper limit of the reference range, the evolution over time (increase or decrease) and the course of the abnormality (acute or chronic).
dc.formatapplication/pdf
dc.identifier.citationSatué, K., Miguel-Pastor, L., Chicharro, D. & Gardón, J. C. (2022). Hepatic enzyme profile in horses. Animals, vol. 12, i. 7 (29 mar.), art. 861. DOI: https://doi.org/10.3390/ani12070861
dc.identifier.doihttps://doi.org/10.3390/ani12070861
dc.identifier.issn2076-2615 (Electrónico)
dc.identifier.urihttp://hdl.handle.net/10637/14147
dc.language.isoen
dc.publisherMDPI
dc.relation.ispartofAnimals. Basilea (Suiza) : MDPI. Vol. 12, i. 7 (29 mar. 2022)
dc.rightsopen access
dc.rights.cchttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectHorses - Digestive organs - Diseases - Diagnosis.
dc.subjectCaballos - Aparato digestivo - Enfermedades - Diagnóstico.
dc.subjectLiver cells - Diagnostic use.
dc.subjectCélulas hepáticas - Uso diagnóstico.
dc.titleHepatic enzyme profile in horses
dc.typeArtículo
dspace.entity.typePublicationes
relation.isAuthorOfPublication2ede1b05-f72b-4a8c-b00a-9e9860d1d8b8
relation.isAuthorOfPublication2456f949-6224-4548-bf2b-c33c67c57de3
relation.isAuthorOfPublication.latestForDiscovery2ede1b05-f72b-4a8c-b00a-9e9860d1d8b8

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Hepatic_Satué_ANIMALS_2022.pdf
Size:
435.45 KB
Format:
Adobe Portable Document Format